(Q41113123)

26 September 2017

Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins (English)

1 reference

26 September 2017

J T Safrit

1

1 reference

26 September 2017

B Bonavida

series ordinal

2

1 reference

26 September 2017

1 January 1992

1 reference

Cancer Immunology, Immunotherapy

26 September 2017

1 reference

26 September 2017

34

1 reference

26 September 2017

321-328

1 reference

26 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01741553

26 September 2017

0 references

cites work

Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.

1 reference

12 December 2020

DNA strand breaks, NAD metabolism, and programmed cell death

1 reference

12 December 2020

Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum

1 reference

12 December 2020

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

12 December 2020

Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism

1 reference

12 December 2020

Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition

1 reference

12 December 2020

Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.

1 reference

12 December 2020

Immunologic control of ovarian cancer

1 reference

12 December 2020

Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor

1 reference

12 December 2020

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

1 reference

12 December 2020

Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages

1 reference

12 December 2020

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity

1 reference

12 December 2020

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

12 December 2020

Vitamin E retards the lipoperoxidation resulting from anticancer drug administration.

1 reference

12 December 2020

Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

12 December 2020

Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity

1 reference

12 December 2020

Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes

1 reference

12 December 2020

Molecular cloning of the complementary DNA for human tumor necrosis factor.

1 reference

12 December 2020

Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity

1 reference

12 December 2020

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

12 December 2020

Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.

1 reference

12 December 2020

Multistage model of natural killer cell-mediated cytotoxicity involving NKCF as soluble cytotoxic mediators

1 reference

12 December 2020

Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741553

1 reference

Dimensions Publication ID

26 September 2017

1010163413

0 references

Fatcat ID

release_cx7wmph5bnhr3mcgj4ofrkhkpi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cx7wmph5bnhr3mcgj4ofrkhkpi

24 November 2022

mapped directly with Wikidata item

1 reference